Resistant Hypertension Workup and Management
The workup for resistant hypertension must include confirmation of true resistance, screening for secondary causes, and a stepwise pharmacologic approach with spironolactone as the preferred fourth agent for most patients. 1
Confirming True Resistant Hypertension
Before initiating extensive workup, confirm true resistant hypertension:
- Definition: BP remaining above goal (>140/90 mmHg) despite concurrent use of 3 antihypertensive agents of different classes at optimal doses, including a diuretic 2
- Rule out pseudo-resistance:
- Ensure proper BP measurement technique (patient seated quietly for 5 minutes, correct cuff size, arm at heart level) 2
- Confirm with out-of-office measurements (24-hour ambulatory BP monitoring preferred) 2
- Assess medication adherence through direct questioning and consider objective evaluation (blood/urine drug levels) 2
- Review medication list for interfering substances (NSAIDs, stimulants, certain antidepressants) 1
Diagnostic Workup
Medical History
- Duration, severity, and progression of hypertension
- Response to prior medications and adverse events
- Current medications (including OTC and herbal supplements)
- Symptoms of secondary causes:
- Sleep apnea: daytime sleepiness, loud snoring, witnessed apnea
- Renal artery stenosis: history of peripheral/coronary atherosclerotic disease
- Pheochromocytoma: episodic hypertension, palpitations, diaphoresis, headaches
- Primary aldosteronism: muscle weakness, polyuria 2
Physical Examination
- Fundoscopic exam (retinopathy)
- Carotid, abdominal, or femoral bruits (renal artery stenosis)
- Diminished femoral pulses or arm/thigh BP discrepancy (aortic coarctation)
- Cushing's syndrome signs: moon facies, central obesity, abdominal striae 2
Laboratory and Diagnostic Testing
- Basic metabolic panel (renal function, electrolytes)
- Urinalysis and albumin-to-creatinine ratio
- Plasma aldosterone/renin ratio (screen for primary aldosteronism) 1
- Consider sleep study for suspected sleep apnea
- Additional testing based on suspected secondary causes 1
Management Approach
Step 1: Optimize Current Regimen
- Ensure optimal doses of initial 3-drug regimen:
- For patients with eGFR <30 mL/min/1.73m², substitute loop diuretic for thiazide 2, 1
- Reinforce lifestyle modifications:
- Sodium restriction (<2400 mg/day)
- Weight loss if indicated
- Regular physical activity
- DASH diet
- Limited alcohol intake 1
Step 2: Add Fourth Agent
- Spironolactone is the preferred fourth agent (12.5-50 mg daily) 1, 3, 4, 5
- Monitor potassium and renal function
- Consider eplerenone if spironolactone causes side effects (gynecomastia)
- If spironolactone is contraindicated or not tolerated:
Step 3: Further Intensification
- Add hydralazine (start 25 mg three times daily, titrate upward to maximum dose) 1, 6
- Consider minoxidil if BP still not controlled 1
- For patients with continued uncontrolled BP despite optimal medical therapy, refer to hypertension specialist 2
Special Considerations
Secondary Causes
Primary aldosteronism, chronic kidney disease, and obstructive sleep apnea are the most common secondary causes of resistant hypertension 1, 7:
- Primary aldosteronism: Screen with plasma aldosterone/renin ratio
- Chronic kidney disease: Monitor renal function and adjust medications accordingly
- Obstructive sleep apnea: Consider sleep study and CPAP therapy if diagnosed
Medication Adherence
- Poor adherence is a major cause of treatment failure
- Consider single-pill combinations to improve adherence
- Discuss barriers to adherence (cost, side effects, dosing complexity) 2, 1
Referral Criteria
Refer to hypertension specialist if:
- BP remains uncontrolled after 6 months of treatment
- Secondary cause is suspected
- Complex medication regimen is needed 2
Common Pitfalls to Avoid
- Failing to confirm true resistant hypertension with out-of-office measurements
- Inadequate diuretic therapy (insufficient dose or inappropriate choice)
- Overlooking medication nonadherence
- Neglecting to screen for common secondary causes
- Therapeutic inertia (not intensifying treatment despite persistently elevated BP) 1, 3